Reset filters
  • 24 July 2017

Long-acting cabotegravir + rilpivirine injection shows good results at 96 weeks

Read the article
Joseph Eron at IAS 2017. Photo by Liz Highleyman, hivandhepatitis.com
  • 21 July 2017

Few people with HIV starting raltegravir and dolutegravir change therapy because of side-effects

Read the article
  • 13 July 2017

Proton pump inhibitors may blunt CD4 cell gains, cause immune activation, in people with HIV

Read the article
  • 12 July 2017

Non-alcoholic fatty liver disease common in people living with HIV – metabolic disorders are key risk factors

Read the article
  • 5 July 2017

Viral load as low as 400 copies/ml six months after starting ART is associated with a significant ten-year mortality risk

Read the article
  • 28 June 2017

Why are women lost from HIV care during pregnancy? Malawi study shows social support and counselling are critical

Read the article
  • 27 June 2017

HIV drug resistance becoming more common in Zambian infants

Read the article
  • 14 June 2017

HIV drug resistance testing not a priority for resource-limited settings, trial finds

Read the article
  • 30 May 2017

Agreements with cash incentives boost patient adherence to HIV therapy and rates of viral suppression

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.